Epic Sciences
Epic Sciences is a biotechnology company specializing in advanced diagnostics for metastatic breast and prostate cancer, offering genomic profiling and comprehensive blood biopsies to guide therapy selection and monitor disease.
CTDNA Panel for Metastatic Breast Cancer
Epic Sciences offers a 56-gene ctDNA panel specifically designed for genomic profiling of metastatic breast cancer. This panel is covered by Medicare under the MolDX program, making it an accessible option for patients. The panel supports personalized treatment plans by providing detailed genetic insights, helping physicians tailor therapies to the individual needs of each patient.
DefineMBC Blood Biopsy
DefineMBC is Epic Sciences' comprehensive blood biopsy solution for metastatic breast cancer. It includes both cell-based and cell-free analysis derived from a single blood draw. This approach allows for a more holistic view of the cancer, enhancing the ability of healthcare providers to make informed decisions for therapy selection and disease monitoring. DefineMBC is designed to improve the overall management of metastatic breast cancer.
CAP/CLIA-Accredited Laboratory Services
Epic Sciences operates a full-service laboratory accredited by the College of American Pathologists (CAP) and the Clinical Laboratory Improvement Amendments (CLIA). This accreditation ensures high standards in laboratory testing and services. The company also offers extensive research support services, aiding in the development of innovative diagnostic tools and treatments.
Partnerships with Pharmaceutical Companies and Cancer Centers
Epic Sciences collaborates with leading pharmaceutical companies and major cancer centers worldwide. These partnerships aim to enhance patient outcomes by leveraging advanced diagnostic tools and innovative treatment strategies. Through these collaborations, Epic Sciences contributes to the personalization and advancement of cancer therapies, particularly for prostate and breast cancer.
Development of Novel Diagnostics for Cancer Treatment
Epic Sciences is dedicated to developing new diagnostic methods to guide therapy selection and monitor disease progression. The company's focus is on personalizing and improving the treatment and management of prostate and breast cancer. By advancing diagnostic technologies, Epic Sciences aims to enhance the precision and effectiveness of cancer treatments, ultimately improving patient care.